Tarsus Pharmaceuticals Operating Margin Growth & History (TARS)

Tarsus Pharmaceuticals's operating margin was −15.72% for fiscal 2025.

View full Tarsus Pharmaceuticals company overview

Tarsus Pharmaceuticals annual operating margin history

Tarsus Pharmaceuticals annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−15.72%+50.18 pp
20242024-12-31−65.90%+754.63 pp
20232023-12-31−820.53%−577.61 pp
20222022-12-31−242.92%−221.60 pp
20212021-12-31−21.32%—

Tarsus Pharmaceuticals operating margin trends

Between the periods ended 2021-12-31 and 2025-12-31, Tarsus Pharmaceuticals's operating margin increased from −21.32% to −15.72%, a change of +5.59 percentage points. The latest reported quarter, Q2 2026, shows −11.45%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Tarsus Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about TARS yet. Start the conversation.

Write the first post